top of page

Occam Places Eva Jack as COO of Hotspot

HotSpot is a private biotech and an investment of Atlas Venture. The company recently raised $100M in a Series C financing and has a platform addressing a number of major disease states including oncology and rare diseases.

In late 2020, Occam recruited Eva Jack, previously CBO of Mersana Therapeutics, to be the COO in a role that would also encompass Business Development.

bottom of page